Healthcare, Regulatory and Reimbursement Landscape - Nigeria

Published: November 2012
No. of Pages: 128
   

Healthcare, Regulatory and Reimbursement Landscape - Nigeria

Summary

GlobalData, the industry analysis specialist, has released its new report, “Healthcare, Regulatory and Reimbursement Landscape - Nigeria”. An essential source of information and analysis on the Nigerian healthcare, regulatory and reimbursement landscape, this report identifies the key trends in the healthcare market, as well as providing insights on the demographic landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts. In 2011, Nigeria’s population reached 167 million, largely due to increased life expectancy and the high proportion of teenage pregnancies. The mortality rate has been decreasing due to increased funding in the healthcare sector by the government and the initiation of healthcare campaigns throughout the country. The pharmaceutical market was estimated at $774m in 2010, and is expected to reach $2.08 billion by 2020, at a projected CAGR of 10%. The medical device market was worth approximately $214m in 2011.


The positive trends in Nigeria’s healthcare market can be attributed primarily to -
- Improving regulatory environment
- Increase in the number of healthcare facilities
- Increase in per capita income.

Scope

- An overview of the pharmaceutical and medical device markets, including size, segmentation, and key drivers and barriers.
- Profiles and SWOT analyses of the major players in the pharmaceutical and medical device markets. The key players covered for the pharmaceutical market are GlaxoSmithKline, May and Baker Nigeria, Fidson Healthcare Plc, Emzor Pharmaceuticals Industries Ltd and Evans Medical Plc.
- Insightful review of the reimbursement and regulatory landscape, with details of the reimbursement process, regulatory agencies and market authorization processes for new drugs and medical devices.
- Detailed analysis of Nigeria’s political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
- An overview of the opportunities for and challenges to growth in the healthcare market.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the healthcare market in Nigeria.
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical device market segments, and companies likely to impact the healthcare market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnerships.
- Identify, understand and capitalize on the opportunities and challenges in the healthcare market.

Healthcare, Regulatory and Reimbursement Landscape - Nigeria

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 Report Guidance 9
3 Overview of the Pharmaceutical and Medical Devices Market 10
3.1 Pharmaceutical Market 10
3.1.1 Market Overview 10
3.1.2 Supply Channels 12
3.1.3 Market Segments 14
3.1.4 Major Therapeutic Areas 15
3.1.5 Major Players 17
3.2 Medical Device Market 34
3.3 Market Drivers and Barriers 35
3.3.1 Drivers 35
3.3.2 Barriers 36
4 Market Access 38
4.1 Reimbursement and Payer Landscape 38
4.1.1 Overview of the Healthcare System 38
4.1.2 Reimbursement Process 39
4.1.3 Overview of Insurance Providers 41
4.1.4 Patient Share in Healthcare Spending 42
4.1.5 Price Trend in Healthcare Services 43
4.1.6 Pricing Policies 43
4.2 Regulatory Landscape 44
4.2.1 Overview of Regulatory Agencies 44
4.2.2 Marketing Authorization Procedure for Pharmaceutical Products 45
4.2.3 Medical Device Approval Process 46
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 47
4.2.5 Licensing Process for Pharmaceutical Exports and Imports 50
4.2.6 Intellectual Property Rights 52
4.2.7 Clinical Trial Regulations 56
4.2.8 Pharmaceutical Advertising Regulations 56
4.2.9 Pharmacy Regulations 58
4.2.10 Labeling and Packaging Regulations 59
5 Country Analysis 60
5.1 Political Environment 60
5.1.1 Political Structure 60
5.1.2 Analysis of the Current Political Environment 61
5.1.3 Healthcare Policy Initiatives 61
5.2 Economic Landscape 62
5.3 Economic Indicators 64
5.3.1 Gross Domestic Product 64
5.3.2 Gross National Income 68
5.3.3 Inflation 69
5.3.4 Currency Exchange Rate 73
5.3.5 Foreign Direct Investment 74
5.3.6 Foreign Exchange Reserves 75
5.3.7 Trade Balance 76
5.3.8 Government Gross Debt 78
5.3.9 External Debt 79
5.3.10 Major Industries 80
5.4 Demography 81
5.4.1 Population 81
5.4.2 Education and Literacy 95
5.4.3 Employment 97
5.4.4 Disease Burden 98
5.5 Healthcare Infrastructure 99
5.5.1 Healthcare Facilities 99
5.5.2 Healthcare Parameters 104
5.5.3 Environmental Health 106
5.5.4 Healthcare Personnel 109
5.6 Healthcare Expenditure 110
5.6.1 Overview 110
5.6.2 Share of Public and Private Sectors 111
5.6.3 Spending on Pharmaceutical R&D 112
5.7 Trade Associations 113
5.7.1 Pharmaceutical Manufacturers Group of the Manufacturers Association of Nigeria 113
5.7.2 Manufacturers Association of Nigeria 113
5.7.3 Nigerian-German Business Association 113
5.8 Trade Fairs 114
6 Opportunities and Challenges 115
6.1 Opportunities 115
6.2 Challenges 116
7 Appendix 118
7.1 Abbreviations 118
7.2 Bibliography 119
7.3 Methodology 126
7.3.1 Coverage 126
7.3.2 Secondary Research 126
7.3.3 Forecasting 127
7.3.4 Primary Research 127
7.3.5 Expert Panel Validation 127
7.4 Contact Us 127
7.5 Disclaimer 128

1.1 List of Tables
Table 1: Pharmaceutical Market ($m), Nigeria, 2005-2010 11
Table 2: Pharmaceutical Market ($bn), Nigeria, Forecast, 2011-2020 12
Table 3: Distribution Channel, Pharmaceutical Markups (%), Nigeria, 2004 13
Table 4: Generic Prescription Rates in Secondary Healthcare Facilities (%), Nigeria, 2007 14
Table 5: MPR and Mark-ups in the Public Sector, Nigeria, 2004 16
Table 6: Hypertension Treatment Therapy, Disease Case, Share (%), Nigeria, 2008 16
Table 7: Major Products, GlaxoSmithKline, Global, Revenue ($m), 2012 17
Table 8: Late Stage Pipeline, GlaxoSmithKline, 2012 18
Table 9: Major Products, May and Baker, Nigeria, 2012 23
Table 10: Major Products, Fidson, 2012 25
Table 11: Major Products, Emzor Pharmaceutical Industries Ltd, 2012 28
Table 12: Major Products, Evans, 2012 32
Table 13: Foreign Funding for Medical Equipment ($m), Nigeria, 2011-2012 34
Table 14: Medical Device Market, Nigeria, Revenue ($m), 2006-2011 35
Table 15: Health Insurance Program, Social Health Sector, Nigeria, 2011 38
Table 16: Healthcare Spending, Nigeria, Patient’s Share (%), 2005-2010 42
Table 17: Medicine Prices in all Sectors, Nigeria, Private to Public Share (%), 2004 43
Table 18: GDP Per Capita ($), Nigeria, 2006-2011 64
Table 19: GDP Per Capita ($), Nigeria, Forecast, 2011-2020 65
Table 20: GDP, Nigeria, Annual Growth (%), 2006-2011 66
Table 21: GDP, Nigeria, Annual Growth (%), Forecast, 2012-2020 67
Table 22: GNI Per Capita ($), Nigeria, 2006-2011 68
Table 23: GNI Per Capita ($), Nigeria, Forecast, 2012-2020 69
Table 24: Average Consumer Price Index, Nigeria, 2006-2011 69
Table 25: Average Consumer Price Index, Nigeria, Forecast, 2012-2020 70
Table 26: Average Consumer Price, Nigeria, Annual Change (%), 2006-2011 71
Table 27: Average Consumer Price, Nigeria, Annual Change (%), Forecast, 2012-2020 72
Table 28: Currency Exchange Rate (NGN/$), Nigeria, 2006-2011 73
Table 29: Foreign Direct Investment ($bn), Nigeria, 2005-2010 74
Table 30: Foreign Exchange Reserves ($bn), Nigeria, 2006-2011 75
Table 31: Imports ($bn), Nigeria, 2005-2010 76
Table 32: Exports ($bn), Nigeria, 2005-2010 77
Table 33: Government Debt ($bn), Nigeria, 2005-2010 78
Table 34: External Debt ($bn), Nigeria, 2005-2010 79
Table 35: Major Industries, Nigeria, Contribution to GDP (%), 2006-2010 80
Table 36: Population (millions), Nigeria, 2006-2011 81
Table 37: Population (millions), Nigeria, Forecast, 2012-2020 82
Table 38: Urban and Rural Population, Nigeria, Share (%), 2005-2010 83
Table 39: Age Groups, Nigeria, Population Distribution (%), 2005-2010 84
Table 40: Age Groups, Nigeria, Population Distribution (%), Forecast, 2011-2020 85
Table 41: Births (Per 1,000 Population), Nigeria, 2005-2010 86
Table 42: Mortality (Per 1,000 Population), Nigeria, 2006-2011 87
Table 43: Mortality (Per 1,000 Population), Nigeria, Forecast, 2012-2020 88
Table 44: Major Causes of Mortality (Number of Deaths, ’000), Nigeria, 2008 89
Table 45: Children <5 Years Age, Nigeria, Mortality (Per 1,000 Live Births), 2005-2010 89
Table 46: Immunization Rate (%), Nigeria, 2005-2010 90
Table 47: Major Causes of Male Mortality (Number of Deaths, ’000), Nigeria, 2008 91
Table 48: Major Causes of Female Mortality (Number of Deaths, ’000), Nigeria, 2008 92
Table 49: Gender Ratio (M/F), Nigeria, 2005-2010 93
Table 50: Life Expectancy at Birth (Years), Nigeria, 2006-2011 94
Table 51: Levels of Education, Nigeria, Student Enrolment in Universities (‘000), 2005-2010 95
Table 52: Levels of Education, Nigeria, Student Enrolment in Colleges (‘000), 2005-2010 96
Table 53: Levels of Education, Nigeria, Student Enrolment in Schools (‘000), 2005-2010 97
Table 54: Unemployment Rate (%), Nigeria, 2006-2011 97
Table 55: Major Diseases, Nigeria, DALY (Per 100,000 Population), 2004 99
Table 56: Number of Healthcare Centers, Nigeria, 2005-2010 100
Table 57: Number of Public and Private Healthcare Centers, Nigeria, 2005-2010 101
Table 58: Types of Healthcare Centers (‘000), Nigeria, 2005-2010 102
Table 59: Hospitals by Type of Services, Nigeria, 2007 103
Table 60: Hospital Beds (Per 10,000 Population), Nigeria, 2006-2011 104
Table 61: Number of Physicians (Per 10,000 Population), Nigeria, 2006-2011 105
Table 62: Environmental Attributable Deaths (Per 100,000 Population), Nigeria, 2004 106
Table 63: PM10 (micrograms per cubic meter), Nigeria, 2005-2010 107
Table 64: CO2 Emissions (Million Tons), Nigeria, 2005-2010 108
Table 65: Healthcare Personnel (Per 10,000 Population), Nigeria, 2005-2010 110
Table 66: Healthcare Expenditure (% of the GDP), Nigeria, 2005-2010 111
Table 67: Healthcare Expenditure, Nigeria, Public-Private Share (%), 2005-2010 111
Table 68: GERD, Nigeria, Share (%), 2007 112
Table 69: GERD, Type of R&D, Nigeria, Share (%), 2007 113
Table 70: Major Healthcare Trade Fairs, Nigeria, 2011-2012 114

1.2 List of Figures
Figure 1: Pharmaceutical Market ($m), Nigeria, 2005-2010 11
Figure 2: Pharmaceutical Market ($bn), Nigeria, Forecast, 2011-2020 12
Figure 3: Distribution Channels, Nigeria, 2011 13
Figure 4: Medical Device Market, Nigeria, Revenue ($m), 2006-2011 35
Figure 5: Drivers and Barriers, Healthcare Market, Nigeria, 2011 37
Figure 6: Financial Flow in the Healthcare System, Nigeria, 2012 39
Figure 7: National Healthcare Finance Scheme, Nigeria, 2012 41
Figure 8: Healthcare Spending, Nigeria, Patient’s Share (%), 2005-2010 42
Figure 9: Marketing Authorization Procedure, Nigeria, 2012 45
Figure 10: Medical Device Approval Process, Nigeria, 2012 47
Figure 11: Licensing Process for Pharmaceutical Manufacturing, Nigeria, 2012 48
Figure 12: Licensing Process for Medical Device Manufacturing, Nigeria, 2012 49
Figure 13: Licensing Process for Medical Device Imports, Nigeria, 2012 51
Figure 14: Licensing Process for Pharmaceutical Exports, Nigeria, 2012 52
Figure 15: Patent Approval Process, Nigeria, 2012 54
Figure 16: Trademark Approval Process, Nigeria, 2012 55
Figure 17: Pharmaceutical Advertisement Approval Process, Nigeria, 2012 57
Figure 18: GDP Per Capita ($), Nigeria, 2006-2011 64
Figure 19: GDP Per Capita ($), Nigeria, Forecast, 2011-2020 65
Figure 20: GDP, Nigeria, Annual Growth (%), 2006-2011 66
Figure 21: GDP, Nigeria, Annual Growth (%), Forecast, 2012-2020 67
Figure 22: GNI Per Capita ($), Nigeria, 2006-2011 68
Figure 23: GNI Per Capita ($), Nigeria, Forecast, 2012-2020 68
Figure 24: Average Consumer Price Index, Nigeria, 2006-2011 69
Figure 25: Average Consumer Price Index, Nigeria, Forecast, 2012-2020 70
Figure 26: Average Consumer Price, Nigeria, Annual Change (%), 2006-2011 71
Figure 27: Average Consumer Price, Nigeria, Annual Change (%), Forecast, 2012-2020 72
Figure 28: Currency Exchange Rate (NGN/$), Nigeria, 2006-2011 73
Figure 29: Foreign Direct Investment ($bn), Nigeria, 2005-2010 74
Figure 30: Foreign Exchange Reserves ($bn), Nigeria, 2006-2011 75
Figure 31: Imports ($bn), Nigeria, 2005-2010 76
Figure 32: Exports ($bn), Nigeria, 2005-2010 77
Figure 33: Government Debt ($bn), Nigeria, 2005-2010 78
Figure 34: External Debt ($bn), Nigeria, 2005-2010 79
Figure 35: Major Industries, Nigeria, Contribution to GDP (%), 2006-2010 80
Figure 36: Population (millions), Nigeria, 2006-2011 81
Figure 37: Population (millions), Nigeria, Forecast, 2012-2020 82
Figure 38: Urban and Rural Population, Nigeria, Share (%), 2005-2010 83
Figure 39: Age Groups, Nigeria, Population Distribution (%), 2005-2010 84
Figure 40: Age Groups, Nigeria, Population Distribution (%), Forecast, 2011-2020 85
Figure 41: Births (Per 1,000 Population), Nigeria, 2005-2010 86
Figure 42: Mortality (Per 1,000 Population), Nigeria, 2006-2011 87
Figure 43: Mortality (Per 1,000 Population), Nigeria, Forecast, 2012-2020 87
Figure 44: Major Causes of Mortality (Number of Deaths, ’000), Nigeria, 2008 88
Figure 45: Children <5 Years Age, Nigeria, Mortality (Per 1,000 Live Births), 2005-2010 89
Figure 46: Immunization Rate (%), Nigeria, 2005-2010 90
Figure 47: Major Causes of Male Mortality (Number of Deaths, ’000), Nigeria, 2008 91
Figure 48: Major Causes of Female Mortality (Number of Deaths, ’000), Nigeria, 2008 92
Figure 49: Gender Ratio (M/F), Nigeria, 2005-2010 93
Figure 50: Life Expectancy at Birth (Years), Nigeria, 2006-2011 94
Figure 51: Levels of Education, Nigeria, Student Enrolment in Universities (‘000), 2005-2010 95
Figure 52: Levels of Education, Nigeria, Student Enrolment in Colleges (‘000), 2005-2010 96
Figure 53: Levels of Education, Nigeria, Student Enrolment in Schools (‘000), 2005-2010 96
Figure 54: Unemployment Rate (%), Nigeria, 2006-2011 97
Figure 55: Major Diseases, Nigeria, DALY (Per 100,000 Population), 2004 98
Figure 56: Number of Healthcare Centers, Nigeria, 2005-2010 100
Figure 57: Number of Public and Private Healthcare Centers, Nigeria, 2005-2010 101
Figure 58: Types of Healthcare Centers (‘000), Nigeria, 2005-2010 102
Figure 59: Hospitals by Type of Services, Nigeria, 2007 103
Figure 60: Hospital Beds (Per 10,000 Population), Nigeria, 2006-2011 104
Figure 61: Number of Physicians (Per 10,000 Population), Nigeria, 2006-2011 105
Figure 62: Environmental Attributable Deaths (Per 100,000 Population), Nigeria, 2004 106
Figure 63: PM10 (micrograms per cubic meter), Nigeria, 2005-2010 107
Figure 64: CO2 Emissions (Million Tons), Nigeria, 2005-2010 108
Figure 65: Healthcare Personnel (Per 10,000 Population), Nigeria, 2005-2010 109
Figure 66: Healthcare Expenditure (% of the GDP), Nigeria, 2005-2010 110
Figure 67: Healthcare Expenditure, Nigeria, Public-Private Share (%), 2005-2010 111
Figure 68: GERD, Type of R&D, Nigeria, Share (%), 2007 113
Figure 69: Opportunities and Challenges, Healthcare Market, Nigeria, 2011 117

Published By: GlobalData
Product Code: GlobalData26531


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we’ll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Healthcare market as per your needs. Get the best of Healthcare research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest:

Live Chat
Live Chat by Comm100